Clearmind Medicine Inc. - Common Shares, no par value per share (CMND)
CUSIP: 185053402
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 2,174,400
- Total 13F shares
- 612,804
- Share change
- -89,615
- Total reported value
- $5,491,207
- Price per share
- $1.38
- Number of holders
- 9
- Value change
- -$46,684
- Number of buys
- 5
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 185053402?
CUSIP 185053402 identifies CMND - Clearmind Medicine Inc. - Common Shares, no par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 185053402:
Top shareholders of CMND - Clearmind Medicine Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Gotham Asset Management, LLC |
13F
|
Company |
16%
|
339,008
|
$5,051,215 | — | 30 Sep 2024 | |
| AdvisorShares Investments LLC |
13F
|
Company |
7.8%
|
170,641
|
$208,182 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
6.5%
|
141,337
|
$172,431 | — | 30 Sep 2024 | |
| Cornerstone Wealth Group, LLC |
13F
|
Company |
0.92%
|
20,000
|
$24,400 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.82%
|
17,729
|
$21,629 | — | 30 Sep 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.59%
|
12,756
|
$15,000 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.03%
|
569
|
$1,000 | — | 30 Sep 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.02%
|
379
|
$462 | — | 30 Sep 2024 |
Institutional Holders of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) as of Q4 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.